학술논문
PMH70 DIRECT HEALTHCARE COSTS FOR THE MANAGEMENT OF PATIENTS WITH OPIOID USE DISORDER TREATED WITH METHADONE AND BUPRENORPHINE/NALOXONE IN REAL-WORLD SETTING IN SPAIN. COSTEDOPIA STUDY.
Document Type
Article
Author
Source
Subject
*OPIOID abuse
*MEDICAL care costs
*COST control
*DIRECT costing
*METHADONE hydrochloride
*
*
*
*
Language
ISSN
1098-3015
Abstract
PMH70 DIRECT HEALTHCARE COSTS FOR THE MANAGEMENT OF PATIENTS WITH OPIOID USE DISORDER TREATED WITH METHADONE AND BUPRENORPHINE/NALOXONE IN REAL-WORLD SETTING IN SPAIN. To evaluate the economic impact in patients with Opioid Use Disorder (OUD) treated with methadone or buprenorphine/naloxone (B/N) in routine clinical practice in Spain. In a real-world setting, treatment of OUD patients with B/N results in direct healthcare cost savings, compared to methadone. [Extracted from the article]